Another Dispatch From the Accumulator-Maximizer Wars
Vanderbilt’s Stacie Dusetzina and colleagues explain how the ‘copay adjustment’ programs work in this week’s JAMA Internal Medicine and...
Another Dispatch From the Accumulator-Maximizer Wars
Former Gov. Jane Swift testifies on medication access
1 in 5 older adults skipped or delayed medications last year because of cost
House panel advances bill to promote PBM transparency
Report: “Specialty” drugs are by far the most expensive, but classification seems arbitrary
Powerful Senate duo drops a bipartisan PBM reform plan
Pharmacy benefit managers are picking patients' pockets
What is transparency? 6 things to look for in a PBM contract
Drug middlemen switch tactics, but the outcome is the same: high prices
National Poll Shows Overwhelming Support for Congressional Efforts to Hold PBMs Accountable
NACDS Praises New Congressional Investigation of PBMs
APhA releases survey results quantifying the impact of PBMs
Pharmacy Benefit Managers Put in Crosshairs of Drug Price Fight
Private Health Care Companies Are Eating the American Economy
Workplace health plans pay up to 30 times more than Medicare for specialty drugs
Senate bill aims to crack down on how drug company ‘middlemen’ negotiate prices
Patients needing home IV nutrition fear dangerous shortages
Oklahoma Pharmacy Board unanimously approves new rules for shipping mail-order medications
A decade-long battle over Medicare Advantage audits is coming to a head
It is Time for Policymakers to Protect Patients from Predatory Practices of Insurers and PBMs